A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

NCT02095158 ↗

Phase 3 Completed 440 enrolled Allergan

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride (HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.

Timeline

Start: 2014-04
Primary completion: 2015-08
Completion: 2015-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxymetazoline	Other / unclassified	1 %	Topical

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

Summary

Timeline

Drugs

Indications